Business
– NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario
– NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario.
About this update from Eko International Corporation
[{"type":"text","content":" EKO International Corp – NeroVasc Clinical Inc. Presentation at the Canadian Federation of Podiatric Medicine Conference, London, Ontario EKO International Inc. (EKNL – Pinksheets) is pleased to announce that NeuroVasc Clinical Inc. (NCI) will be presenting FREMS (Frequency Rhythmic Electrical Modulation System) devices at the Canadian Federation of Podiatric Medicine13th Annual Conference in London, Ontario on October 26th and 27th,2012. The two day event offers chiropodists,podiatrists, medical office staff and other health professionals the opportunity to attend an educational conference that is essential to their professional development. The conference contains lectures related to podiatric medicine delivered by renowned international speakers. The attendees will be offered interactive seminars, hands on workshops and various equipment demonstrations. Dr. Paul Ziemer of NCI will bespeaking to participants and leading them through hands on training sessions for the NC-stat DPN Check device “a fast, accurate, and quantitative point-of-care test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy” which helps to determine the need for treatment that only FREMS may be able to deliver.NCI is also a distributor of this device. FREMS will be displayed, demonstrated and offered to health practitioners during this two day conference. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EKO International (“The Company”) are \"forward-looking statements\" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity,performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looki...